Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future.
Dalakas
Marinos C
MC
Neuromuscular Diseases Section, NINDS, NIH, Building 10, Room 4N248, 10 Center Drive MSC 1382, Bethesda, MD 20892-1382, USA. dalakasm@ninds.nih.gov
D003882:Dermatomyositis / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy / Q000639:trends*; D009220:Myositis / Q000188:drug therapy* / Q000276:immunology*; D018979:Myositis, Inclusion Body / Q000188:drug therapy / Q000276:immunology; D017285:Polymyositis / Q000188:drug therapy / Q000276:immunology
D007155:Immunologic Factors; D007166:Immunosuppressive Agents